As global markets face pressures from rising U.S. Treasury yields, the Hong Kong market has experienced a decline in its benchmark Hang Seng Index, reflecting broader economic uncertainties and investor caution. In this environment, dividend stocks can offer a measure of stability and income potential for investors looking to navigate these turbulent times.
Top 10 Dividend Stocks In Hong Kong
| Name | Dividend Yield | Dividend Rating |
| China Hongqiao Group (SEHK:1378) | 9.40% | ★★★★★☆ |
| Bank of China (SEHK:3988) | 7.12% | ★★★★★☆ |
| Playmates Toys (SEHK:869) | 8.70% | ★★★★★☆ |
| China Construction Bank (SEHK:939) | 7.20% | ★★★★★☆ |
| PC Partner Group (SEHK:1263) | 8.73% | ★★★★★☆ |
| Chongqing Rural Commercial Bank (SEHK:3618) | 7.30% | ★★★★★☆ |
| Tianjin Development Holdings (SEHK:882) | 7.13% | ★★★★★☆ |
| China Mobile (SEHK:941) | 6.69% | ★★★★★☆ |
| Shougang Fushan Resources Group (SEHK:639) | 10.00% | ★★★★★☆ |
| Sinopharm Group (SEHK:1099) | 4.82% | ★★★★★☆ |
Click here to see the full list of 91 stocks from our Top SEHK Dividend Stocks screener.
Let's uncover some gems from our specialized screener.
JBM (Healthcare) (SEHK:2161)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: JBM (Healthcare) Limited is an investment holding company involved in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products across Hong Kong, Macau, Mainland China, and internationally with a market cap of HK$802.72 million.
Operations: JBM (Healthcare) Limited generates its revenue through three main segments: Branded Medicines (HK$190.11 million), Health and Wellness Products (HK$72.19 million), and Proprietary Chinese Medicines (HK$386.12 million).
Dividend Yield: 8.3%
JBM (Healthcare) recently announced a final dividend of HK$0.0405 per share, supported by a payout ratio of 50.8% and cash payout ratio of 36.7%, indicating dividends are well-covered by earnings and cash flows. Despite only two years of dividend payments, the company shows reliability with stable growth in dividends and earnings increasing by 128.5% last year. A recent buyback program could enhance net asset value per share, potentially benefiting future dividends.
- Click here to discover the nuances of JBM (Healthcare) with our detailed analytical dividend report.
- Insights from our recent valuation report point to the potential undervaluation of JBM (Healthcare) shares in the market.
Pak Fah Yeow International (SEHK:239)
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Pak Fah Yeow International Limited is an investment holding company that manufactures, markets, and distributes healthcare products under the Hoe Hin brand name, with a market cap of HK$782.22 million.
Operations: Pak Fah Yeow International Limited generates revenue from its healthcare segment amounting to HK$247.67 million, property investments at HK$10.03 million, and treasury investments totaling HK$7.52 million.
Dividend Yield: 8.6%
Pak Fah Yeow International's dividend payments have been volatile over the past decade, but they are well-covered by earnings (payout ratio: 22%) and cash flows (cash payout ratio: 38.9%). The company recently announced a special interim dividend of HK$0.065 per share alongside a regular interim dividend of HK$0.03 per share for the first half of 2024, despite a slight decrease in net income to HK$47.41 million from HK$55.99 million the previous year due to unrealized fair value losses on investment properties.
- Delve into the full analysis dividend report here for a deeper understanding of Pak Fah Yeow International.
- In light of our recent valuation report, it seems possible that Pak Fah Yeow International is trading beyond its estimated value.
Wasion Holdings (SEHK:3393)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Wasion Holdings Limited is an investment holding company that focuses on the research, development, production, and sale of energy metering and energy efficiency management solutions for energy supply industries across various regions including China, Africa, the United States, Europe, and Asia with a market cap of approximately HK$5.77 billion.
Operations: Wasion Holdings Limited generates its revenue through three primary segments: Advanced Distribution Operations (CN¥2.51 billion), Power Advanced Metering Infrastructure (CN¥2.99 billion), and Communication and Fluid Advanced Metering Infrastructure (CN¥2.42 billion).
Dividend Yield: 4.9%
Wasion Holdings' dividend payments, while covered by earnings (payout ratio: 40%) and cash flows (cash payout ratio: 39%), have been unstable over the past decade. Despite a low dividend yield of 4.86% compared to top-tier payers in Hong Kong, dividends have grown over ten years. Recent results show a significant rise in net income to CNY 331.03 million for H1 2024, driven by increased sales and cost control measures, suggesting potential for future stability.
- Click to explore a detailed breakdown of our findings in Wasion Holdings' dividend report.
- The valuation report we've compiled suggests that Wasion Holdings' current price could be quite moderate.
Taking Advantage
- Navigate through the entire inventory of 91 Top SEHK Dividend Stocks here.
- Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
- Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.
Ready For A Different Approach?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SEHK:2161
JBM (Healthcare)
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
Flawless balance sheet with solid track record.
